Company profile
Verisante Technology Inc.
OTC: VRSEF · Healthcare · Medical - Devices
Canadian filerHQ Vancouver, BCReports USD
#1161 of 1,417 Healthcare companies by revenue
EA Score
——FH 33DQ —GM —SS 42
v0.1 · 35/100 weight · pillars only
↑ return on assets, listing tenure · ↓ Altman-Z, balance-sheet leverage
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
$22.3k
Employees
18
as of 2026-08-28
Market cap
$179.5k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income$22.3k31.2k CAD2025
Operating income-$82.8k-115.8k CAD2025
Total assets$3.6k4.9k CAD2025
Liabilities$32.0k43.8k CAD2025
Equity-$28.4k-38.9k CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Verisante Technology Inc.’s revenue?
Verisante Technology Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a Infinity% net margin.
Peers · Healthcare
Medical Cannabis Payment Solutions——GRI Bio, Inc.——Health Logic Interactive Inc.——Innovation Pharmaceuticals Inc.——TripSitter Clinic Ltd.——Indigenous Bloom Hemp Corp.——Key facts
CEOThomas A. Braun
SectorHealthcare
IndustryMedical - Devices
HeadquartersVancouver, BC
ExchangeOTC: VRSEF
Employees18
IPO date2011-05-06
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.